Kineta to Present at 22nd Annual Needham Healthcare Conference
SEATTLE, April 03, 2023 -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, a ...